novo nordisk a/s-b (NOVOB:Copenhagen)
Heath Lukatch Ph.D.
Executive Officer of San Francisco Office,Novo Nordisk A/S
|Age||Total Calculated Compensation||This person is connected to 80 board members in 9 different organizations across 18 different industries.|
See Board Relationships
Mr. Heath Lukatch, Ph. D., is Partner and Managing Director at TPG Biotech. He was a Partner at Novo A/S where he helped establish Novo Ventures’ San Francisco office. He was employed at the firm for nine years. Mr. Lukatch had been an Executive Officer at Novo Nordisk A/S since May 18, 2006. Mr. Lukatch joined Novo A/S in 2006. Prior to joining Novo Ventures, Mr. Lukatch was responsible for biotechnology venture investments at Piper Jaffray Ventures. From 2001 to 2006, ...
Novo AlléPhone: 45 44 44 88 88
Bagsvaerd, Capital Region of Denmark 2880
Fax: 45 44 49 05 55
Board Members Memberships*
Chairman of the Board
Chairman of The Board
Chairman and Chairman of Compensation, Nominating & Governance Committee
Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
University of California Berkeley
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|Giovanni Caforio M.D.||Chief Executive Officer and Director|
Bristol-Myers Squibb Company
|Brenton L. Saunders J.D.||Chief Executive Officer, President and Director|
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.6M||Compensation as of Fiscal Year 2014.|